Batavia Biosciences is a contract development and manufacturing organization with expertise in viral vaccines, virotherapy, proteins and antibodies. We are not your standard CDMO – our customers regularly refer to us as their product development partner and thought partner.
How Batavia helps to reduce human suffering from infectious diseases and cancer
We accelerate the journey to the clinic by improving product yields, reducing process development time and increasing product stability. Our services and technologies have demonstrated to reduce risks, improve timelines and reduce costs in biopharmaceutical development to ensure the product reaches the patient without any unnecessary delays.
100
experts with industry experience
500
projects successfully completed
97
successful runs under GMP
70
returning customers
Latest resources from learning center
Severe Combined Immunodeficiency (SCID) disease affects 1 in 35,000 newborns annually, of which approximately 145 are babies in the European Union. These children are born without a functional immune system,…
How do you keep cost of goods (COGs) for viral vector-based medicines within reason to develop a product that is both affordable and financially viable? In this 3-part series we…
Eize De Boer showed us what it takes to realize a new facility for Batavia Biosciences designed for viral vector manufacturing to support developers on a global scale. The multi-product facility is designed…
Date: Nov 1-3 Location: Frankfurt, Germany Contact: Pieter-Jan Vos It’s time for one of the best bioprocessing events of the year! Come join us at CPHI Frankfurt at Booth #91G03.…
Talk to our experts
